AI assistant
Sending…
Anterix Inc. — Director's Dealing 2021
Sep 9, 2021
33018_dirs_2021-09-08_b5e2ec8a-087b-42a6-a96d-aa495b3a7bf7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-09-07
Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-07 | Stock Option (Right to Buy) | $60.92 | A | 65595 | Acquired | 2031-09-07 | Common Stock (65595) | Direct |
Footnotes
F1: 33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter.
More from Anterix Inc.
Fund Information / Factsheet
2026
Apr 21
Regulatory Filings
2026
Apr 21
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 1
Earnings Release
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 19